Werner syndrome gene variants in human sarcomas

Area of Science:

• Genetics
• Molecular Biology
• Oncology

Background:

• Werner syndrome (WS) is an autosomal inherited disorder causing premature aging.
• Individuals with WS exhibit a high incidence of sarcomas.
• The WRN gene, encoding DNA helicase and exonuclease, is implicated in WS.

Purpose of the Study:

• To investigate mutations or single nucleotide polymorphisms (SNPs) in the WRN gene within spontaneous sarcomas.
• To determine if WRN alterations in non-WS sarcomas contribute to cancer development.

Main Methods:

• Analysis of RNA or DNA sequences in helicase and exonuclease domains of WRN.
• Comparison of sequences from 51 sarcoma tissues and 69 adjacent normal tissues.
• Characterization of novel identified mutations, including P204L WRN.

Main Results:

• Identified three novel nonsynonymous substitutions in WRN: c.611C>T, c.809_810insT, and c.1882C>G.
• The c.611C>T mutation (P204L WRN) significantly reduced WRN exonuclease activity (approx. 10-fold).
• Helicase activity of P204L WRN showed a less than twofold reduction.

Conclusions:

• Novel WRN mutations occur in spontaneous sarcomas.
• The P204L WRN variant exhibits impaired exonuclease function, suggesting a role in sarcoma development.
• Further research is warranted to understand the implications of WRN mutations in sporadic cancers.